Trials / Completed
CompletedNCT04094103
Strawberry Consumption in Overweight and Obese Individuals
Integrated Cardiovascular and Metabolic Effects of Strawberry Consumption in Overweight and Obese Individuals
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Carl Ade, M.S., Ph.D. · Academic / Other
- Sex
- All
- Age
- 35 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
Our proposal represents an integrated approach to determining the cardiovascular and metabolic effects of strawberry consumption in adults who have high risk for cardiometabolic disease.
Detailed description
The current proposal aims to fill some of these important research gaps with regard the dose and time-course of strawberry consumption in a population where dietary intervention may of particular benefit for both primary and secondary prevention of cardiovascular and metabolic disease. Participants will participate in a double blind, placebo-controlled, randomized crossover trial. Following a 10-day run-in where no berries are consumed, participants will be randomized via Latin-square design, to three different daily strawberry powder conditions for 4-weeks at a time, with a 7 day washout between conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Active strawberry powder | Participants will drink a strawberry beverage with active ingredients once a day during the 4-week intervention period. |
| DIETARY_SUPPLEMENT | Placebo strawberry powder | Participants will drink a strawberry placebo beverage once a day during the 4-week intervention period. |
| DIETARY_SUPPLEMENT | Mixed strawberry powder | Participants will drink a mixed strawberry beverage with active ingredients and placebo once a day during the 4-week intervention period. |
Timeline
- Start date
- 2019-10-01
- Primary completion
- 2023-10-27
- Completion
- 2023-10-27
- First posted
- 2019-09-18
- Last updated
- 2025-09-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04094103. Inclusion in this directory is not an endorsement.